CONTOUR NEXT
Report
- Report Number
- 1810909-2020-00099
- Event Type
- Malfunction
- Date Received
- February 24, 2020
- Date of Event
- January 28, 2020
- Report Date
- January 28, 2020
- Manufacturer
- ASCENSIA DIABETES CARE US INC.
- Product Code
- NBW
- PMA / PMN Number
- K110894
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- US
- Reporter Occupation
- OTHER
Narratives
THE CUSTOMER DID NOT RETURN THE SUSPECTED DEVICE FOR EVALUATION. THEREFORE, THE IN-HOUSE CONTOUR NEXT LINK 2.4 METER AND IN-HOUSE CONTOUR NEXT LINK METER WERE TESTED WITH THE IN-HOUSE CONTOUR NEXT TEST STRIPS USING A BLOOD SAMPLE, WHICH GAVE A SATISFACTORY PERFORMANCE.
THE PATIENT/FAMILY WAS THE INITIAL REPORTER, SO PERSONAL INFORMATION WAS NOT ENTERED. NO INFORMATION WAS CAPTURED AS THE CUSTOMER'S AGE AND WEIGHT WERE NOT PROVIDED. THE CUSTOMER DID NOT PROVIDE THE PRODUCT INFORMATION. THEREFORE, NO INFORMATION WAS CAPTURED (MODEL #, LOT #, EXPIRATION DATE) AND DEVICE MANUFACTURE DATE COULD NOT BE DETERMINED. PMA/510K INDICATES THE 510(K)# FOR CONTOUR NEXT LINK METER. PMA/510K CAN ONLY BE UPDATED WITH ONE 510(K)/PMA #. AS THE CUSTOMER WAS UNSURE OF HER DEVICE TYPE, THE PMA# FOR CONTOUR NEXT LINK 2.4 IS CAPTURED IN THIS SECTION. PMA # FOR CONTOUR NEXT LINK 2.4 IS P150001.
THE CUSTOMER REPORTED THAT HER BLOOD GLUCOSE READING ON THE ASCENSIA METER WAS 30 TO 40 MG/DL HIGHER COMPARED TO THAT OBTAINED ON THE NON-ASCENSIA METER. THE CUSTOMER WAS UNSURE OF THE TYPE OF METER SHE HAD BETWEEN THE CONTOUR NEXT LINK AND CONTOUR NEXT LINK 2.4 METER. NO SPECIFIC READINGS WERE PROVIDED. THERE WAS NO ALLEGATION OF AN ADVERSE EVENT. UPON FOLLOW-UP, THE CUSTOMER MENTIONED THAT THE METER WAS FUNCTIONING PROPERLY. THEREFORE, THE DEVICE IS NOT EXPECTED TO BE RETURNED FOR EVALUATION.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 210820 | CONTOUR NEXT | BLOOD GLUCOSE TEST STRIPS | NBW | ASCENSIA DIABETES CARE US INC. |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 |